Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ETTX - Entasis Therapeutics shares rise after lining up ETX0462 poster presentation

ETTX - Entasis Therapeutics shares rise after lining up ETX0462 poster presentation

Entasis Therapeutics Holdings Inc.
Entasis Therapeutics (ETTX) announces that it will present 11 posters with one oral presentation highlighting the company's ETX0462 treatment, a novel, diazabicyclooctane with antimicrobial activity against Pseudomonas aeruginosa.Shares up nearly 6% premarket.Presentations will include updates on: SUL-DUR, a ?-lactam/?-lactamase inhibitor currently in a Phase 3 registrational clinical trial to treat infections caused by carbapenem-resistant Acinetobacter baumannii.and ETX0282CPDP, an oral ?-lactam/?-lactamase inhibitor being developed to treat multidrug-resistant Gram-negative pathogens, including those caused by extended-spectrum ?-lactamases ((ESBLs)) and carbapenem-resistant Enterobacteriaceae ((CRE)).

For further details see:

Entasis Therapeutics shares rise after lining up ETX0462 poster presentation
Stock Information
Company Name: Entasis Therapeutics Holdings Inc.
Stock Symbol: ETTX
Market: NASDAQ
Website: entasistx.com
Menu
ETTX ETTX Quote ETTX Short ETTX News ETTX Articles ETTX Message Board
Get ETTX Alerts

News, Short Squeeze, Breakout and More Instantly...